company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1082000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3652000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4734000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4734000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,70000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,70000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4664000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4677000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4677000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4677000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.73
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.73
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6358266.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q2,2012-04-01,2012-06-30,2013-08-13 16:06:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.73
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1717000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4249000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5966000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5966000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,34000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,34000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5932000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5946000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5946000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5946000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,6400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.93
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,6400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.93
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,6361093.0
Mirati Therapeutics Inc,MRTX,,0001576263,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:00:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.93
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2524000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5475000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7999000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7999000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3801000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3801000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4198000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4217000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4217000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4217000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9957739.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10078232.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10000000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q1,2013-01-01,2013-03-31,2014-05-15 16:13:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.42
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2382000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4510000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6892000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6892000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1079000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1079000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7971000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8012000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8012000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8012000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10000000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.8
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10000000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.8
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,9957725.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q2,2013-04-01,2013-06-30,2014-08-08 16:20:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.8
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3717000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5492000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9209000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9209000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20134000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20134000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29343000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,55000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29398000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29398000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29398000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,9957896.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.95
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,9957896.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.95
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10000000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:09:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.95
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2554000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4320000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1025000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7899000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7899000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3471000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3471000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11370000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-138000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11232000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11232000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11232000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11100000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11100000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11057040.0
Mirati Therapeutics Inc,MRTX,,0001576263,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2685000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4960000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,334000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7979000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7979000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5677000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5677000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13656000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13656000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13656000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13656000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.01
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.01
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13457400.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:06:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.01
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2986000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7149000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10135000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10135000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-903000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-903000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11038000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11038000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11038000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11038000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.82
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.82
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13498828.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 16:06:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.82
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3662000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6886000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10548000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10548000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1931000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1931000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8617000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8617000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8617000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8617000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13527113.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.64
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14717253.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.72
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:26:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.64
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3366000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7076000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10442000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10442000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,72000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,72000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10387000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10387000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10387000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10387000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.77
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13483467.0
Mirati Therapeutics Inc,MRTX,,0001576263,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.77
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3779000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8207000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11986000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11986000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,46000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,46000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11940000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11940000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11940000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11940000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.77
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.77
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15453534.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:27:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.77
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4240000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11276000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15516000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15516000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,70000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,70000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15446000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15446000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15446000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15446000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16300000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.95
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16300000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.95
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16235261.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 16:14:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.95
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4161000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14563000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18724000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18724000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18741000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18741000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18741000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18741000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16900000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.11
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16900000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.11
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16841954.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q3,2015-07-01,2015-09-30,2016-11-03 16:20:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.11
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3575000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14913000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18488000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18488000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,71000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,71000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18417000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18417000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18417000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18417000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16900000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.99
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16901826.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.99
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16901826.0
Mirati Therapeutics Inc,MRTX,,0001576263,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.99
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4130000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17988000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22118000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22118000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,204000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,204000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21914000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21914000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21914000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21914000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.13
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.13
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19380840.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:18:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.13
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3786000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18441000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22227000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22227000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,166000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,166000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22061000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22061000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22061000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22061000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19900000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.11
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19900000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.11
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19912938.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:13:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.11
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3475000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16106000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19581000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19581000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,160000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,160000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19421000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19421000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19421000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19421000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20000000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.97
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20000000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.97
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19924005.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 17:15:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.97
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3901000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15952000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19853000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19853000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,131000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,131000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19722000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19722000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19722000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19722000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,19800000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.99
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,19800000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.99
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,19787349.0
Mirati Therapeutics Inc,MRTX,,0001576263,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.99
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3693000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14397000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18090000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18090000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,244000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,244000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17846000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17846000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17846000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17846000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.73
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.73
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24383941.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q1,2017-01-01,2017-03-31,2018-05-07 16:34:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.73
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3654000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14962000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18616000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18616000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,277000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,277000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18339000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18339000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18339000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18339000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,24800000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.74
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,24800000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.74
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24950012.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:40:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.74
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3119000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13482000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16601000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16601000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,251000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,251000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16350000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16350000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16350000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16350000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25200000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25200000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,24970905.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:24:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2984000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15244000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18228000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18228000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,333000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,333000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17895000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17895000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17895000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17895000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25300000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.66
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25300000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.66
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25290222.0
Mirati Therapeutics Inc,MRTX,,0001576263,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.66
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9467000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9467000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9467000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5154000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19659000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24813000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15346000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,637000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,637000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14709000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14709000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14709000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14709000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28800000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28800000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28843578.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 16:16:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4841000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23829000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28670000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28670000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,801000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,801000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27869000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27869000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27869000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27869000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29600000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.94
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29600000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.94
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29757986.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:22:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.94
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5313000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23626000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28939000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28939000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1371000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1371000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27568000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27568000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27568000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27568000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.85
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.85
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32410407.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 17:22:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.85
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3459000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3459000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3459000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6373000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26758000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33131000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29672000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1400000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28272000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28272000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28272000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28272000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30900000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.89
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30900000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.89
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30897717.0
Mirati Therapeutics Inc,MRTX,,0001576263,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.89
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1244000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1244000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1244000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9762000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34240000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44002000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42758000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1846000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1846000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40912000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40912000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40912000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40912000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35000000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.17
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35000000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.17
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34980361.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:25:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.17
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,577000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,577000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,577000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9894000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38324000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48218000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47641000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1946000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1946000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-45695000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45695000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45695000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-45695000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36300000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.26
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36300000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.26
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36173605.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:22:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.26
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,988000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,988000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,988000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10685000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47362000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58047000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-57059000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2786000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2786000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-54273000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54273000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54273000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-54273000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39300000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.38
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39300000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.38
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39197213.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 17:22:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.38
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,526000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,526000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,526000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12232000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62940000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,75172000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-74646000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2270000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2270000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-72376000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-72376000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-72376000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-72376000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.88
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37500000.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.88
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37467505.0
Mirati Therapeutics Inc,MRTX,,0001576263,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.88
